Concert Pharma Reports Second Quarter 2017 Financial Results And Provides Company Update Post author:Sam Post published:August 7, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society September 14, 2017 Massachusetts??? Homology Medicines Snags $83.5M to Advance AMEnDR into Human Trials July 31, 2017 Sweden's Active Biotech is Strapped for Cash and May Not Survive 2018 December 7, 2017
Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society September 14, 2017